USA / Importing Drugs from Canada: America’s Zombieland Sequel
Market access and pricing expert Barbara Jaszewski outlines the issues inherent in the USA importing drugs from…
canada
Canada / Federal Consultations on a National Strategy for Rare Disease Drugs
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health Canada's consultation with Canadians on what a national strategy for high-cost rare disease…
Canada / The Evolution of Medical Cannabis Legislation
Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its…
Canada / Has the Time Truly Come for Trudeau’s ‘National Pharmacare’?
As the only country in the world to boast a universal healthcare system that does not cover prescription drugs,…
In Conversation
The bright future of mRNA technology – InConversation Podcast #Episode1: w/Thomas D. Madden, Founder, Acuitas Therapeutics
Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer and BioNTech’s COVID-19 vaccine, the numerous applications of the company’s proprietary lipid nanoparticle (LNP) delivery technology, as well as the growth strategy of the Canadian company. pharmaboardroom · The bright future of mRNA technology w/Acuitas Therapeutics
Data / Canada Pharma Snapshot 2020
Up-to-date data and infographics on the Canadian pharma market including an overview of market dynamics,…
Related Report
Canada / COVID-19 Vaccination Strategies
Fasken Canada’s Dara Jospe and Denis Douville examine Canada’s COVID-19 vaccine strategy, from the…
Comprehensive Access to Medicines should be the Priority for National Pharmacare…
Canada is the only developed country with a universal healthcare system that does not provide universal coverage of…
Opinion / A New Approach to Rare Diseases in Canada
Pamela Fralick of Innovative Medicines Canada (IMC) advocates for a collaborative multi-stakeholder approach to…
Canada / Has the Time Truly Come for Trudeau’s ‘National Pharmacare’?
As the only country in the world to boast a universal healthcare system that does not cover prescription drugs,…
Canada / Pharma News Roundup September 2020
The latest news from Canadian pharma including deals for J&J’s and Novavax’s COVID-19 vaccines, an abrupt…
Canada / Collective Impact in the Health Charity Sector
Diabetes Canada’s Jan Hux outlines how her organization has been able to shift from small, local programs to…
Canada’s Cannabis Pioneers Go Global
As Canada’s emergent medical cannabis industry develops at home, several of the country’s leading companies are…
Canada: Targeting Rare Diseases
The research areas in which Canada has the potential to excel are numerous, one being the world of genomics. The…
Canada’s Medical Cannabis Industry Comes of Age
Despite its relative youth, Canada’s medical cannabis industry is already presenting some of the characteristics…
Alzheimer's / Canadian-Led Innovation Post-Aducanumab
Dr Neil Cashman looks at the potential impact of US FDA approval for Biogen’s aducanumab on the search for…
Pharma Faces / Marina Vasiliou, Biogen Canada
Marina Vasiliou took the reins as managing director of Biogen Canada in November 2017 after a long and varied…
Canada / Federal Consultations on a National Strategy for Rare Disease Drugs
Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…
Canada: Safeguarding Generics
With cost-cutting measures exacerbating an already fraught regulatory process, the Canadian generics industry is…
USA / Importing Drugs from Canada: America’s Zombieland Sequel
Market access and pricing expert Barbara Jaszewski outlines the issues inherent in the USA importing drugs from…
UK / New Post-Brexit Regulatory Alliance with Australia, Canada, Singapore & Switzerland
When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to…